(2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid, 95.0%, 100mg

2-tert-butyl-6-methyl-1,4-dihydropyrimidin-4-one, 97%, 2.5g

(E)-5-(4-Methoxystyryl)benzene-1,3-diol, 95.0%, 25mg

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

1-(2-Bromoethyl)-1,3-dihydro-2H-Benzimidazol-2-one, 97%, 10g

1,1-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 1g

N-Boc-5-Bromoanthranilic acid, 95.0%, 10g

tert-Butyl (1S,2R,5R)-2-(hydroxymethyl)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate, 100mg

2-methoxy-4-{[(2-methylpropyl)amino]methyl}phenol, 95.0%, 1g

Benzo[d][1,3]dioxol-4-ylmethanamine, 95.0%, 5g

3-(Chloromethyl)-2-fluoropyridine, 95.0%, 1g

2-(2,6-Dioxo-3-piperidinyl)-4-ethynyl-1H-isoindole-1,3(2H)-dione, 100mg

2-CHLOROSTYRENEOXIDE, 95.0%, 1g